Will Donald Trump Really Cut US Prescription Drug Prices by 80%?
Click to start listening
Synopsis
In a bold move, President Donald Trump promises to slash US prescription drug prices by up to 80%. This new executive order aims to provide immediate relief to American consumers burdened by high medication costs while addressing the longstanding issue of inflated pharmaceutical prices compared to other countries. Will this promise hold true?
Key Takeaways
- Trump's new order aims to reduce drug prices by 30% to 80%.
- Immediate relief for American consumers is promised.
- The policy ties US drug prices to the lowest global rates.
- Pharmaceutical companies are accused of exploiting consumers.
- Previous proposals faced legal challenges.
New Delhi, May 12 (NationPress) In a recent executive directive, US President Donald Trump has committed to reducing the costs of prescription medications and pharmaceuticals in the United States by an impressive 30% to 80%.
Using his social media platform Truth Social, Trump indicated that he would sign this order on Monday morning, aiming to provide immediate relief to Americans burdened by high medication expenses.
He highlighted the longstanding frustrations of US consumers who have had to pay significantly elevated prices for medications compared to those in other nations.
“For many years, the world has questioned why prescription drugs and pharmaceuticals in the United States are priced so much higher than elsewhere,” Trump remarked in his post.
“Sometimes, they can be five to ten times more expensive than the identical drug produced in the same laboratory or plant by the same company?”
The forthcoming policy is anticipated to align the prices of drugs sold in the US with the lowest price found in any other country for the same medication, effectively introducing a “most favored nation’s policy,” according to Trump.
“Finally, our nation will be treated justly, and healthcare costs for our citizens will be slashed to unprecedented levels,” he added.
The US president also accused pharmaceutical companies of taking advantage of Americans by citing research and development expenses to rationalize their inflated prices. This initiative is expected to significantly reduce the costs of cancer treatments and other injectable medications in the US.
Moreover, the new policy is likely to elevate prices in other countries to achieve fairness, as Trump stated. “They will increase globally to equalize prices and, for the first time in many years, bring fairness to America!” he expressed.
Trump had previously proposed a similar strategy during his initial term; however, it faced legal challenges and never came to fruition. This time, he asserts, things will be different, promising that this initiative will “save trillions of dollars.”
Point of View
I recognize the significance of President Trump's latest promise to cut prescription drug prices. While the initiative may offer hope for many Americans struggling with healthcare costs, it is crucial to analyze the feasibility of such drastic changes. Transparency in pharmaceutical pricing and equitable access to medications must remain at the forefront of this discussion.
NationPress
09/06/2025
Frequently Asked Questions
What is Trump's plan for prescription drug prices?
President Trump plans to cut prescription drug prices in the US by 30% to 80% through a new executive order, aligning prices with the lowest global rates.
When will the executive order be signed?
Trump has announced that he will sign the executive order on Monday morning.
How will this affect US consumers?
The initiative aims to provide significant relief to US consumers, reducing the high costs of medications.
Will prices rise in other countries?
Yes, the new policy could lead to price increases in other countries to standardize costs and achieve fairness.
Has Trump proposed similar plans before?
Yes, Trump introduced a similar strategy during his first term, but it was blocked in court.
